Real-time US stock option implied volatility surface analysis and expected move calculations for trading strategies. We use options pricing models to derive market expectations for stock movement over different time periods.
Allogene Therapeutics Inc. (ALLO), a clinical-stage biotechnology firm focused on developing allogeneic chimeric antigen receptor T-cell (CAR-T) therapies for cancer treatment, is currently trading at $2.39, representing a 0.84% gain in recent session activity. This analysis outlines key technical levels, market context, and potential scenarios for the stock as of 2026-04-18, with no recent earnings data available for the company at the time of publication. Key observations include a narrow curr
Allogene (ALLO) Stock Virtual Order (Hovering) 2026-04-18 - Market Expert Watchlist
ALLO - Stock Analysis
4924 Comments
1649 Likes
1
Kinshasha
Consistent User
2 hours ago
Anyone else low-key interested in this?
👍 261
Reply
2
Feriha
Trusted Reader
5 hours ago
This unlocked a memory I never had.
👍 229
Reply
3
Ahnesti
Senior Contributor
1 day ago
Indices are moving sideways with occasional spikes, reflecting mixed investor sentiment.
👍 140
Reply
4
Corine
Insight Reader
1 day ago
Free US stock insider buying and selling tracking with regulatory filing analysis for inside information on company health. We monitor corporate insider transactions because company officers often have the best understanding of their business prospects.
👍 61
Reply
5
Coralynn
Regular Reader
2 days ago
Really wish I didn’t miss this one.
👍 138
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.